2024-05-15 08:45:36 ET
Summary
- Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear.
- An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist.
- PFE stock could prove one of the smartest defensive plays to own the rest of 2024 and into 2025, given a major bear market selloff is next for Wall Street.
Pfizer ( PFE )(PFE:CA) has been a losing investment idea for several years, really since peak pandemic demand was reached for its leading COVID vaccines and antiviral prescription drugs. I have mentioned the stock several times as a strong income/yield proposition starting in 2022, with better than sector average valuations. Yet, the share quote has responded with flat to even lower pricing. My last bullish article was posted in December here ....
Read the full article on Seeking Alpha
For further details see:
Pfizer: Best Trading Momentum Since 2021 And 6% Yield